Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma

Abstract excerpt

Neuroblastoma is a pediatric cancer that originates from neural crest cells and is the most common extracranial solid tumor in children under five years of age. While low-risk neuroblastoma often regresses spontaneously, high-risk neuroblastoma poses a significant clinical challenge. Recent advances in understanding neuroblastoma's molecular mechanisms have led to the development of targeted therapies that aim to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ATP Synthase and ATPases Research
• Share to interferon and immune responses
• Share to Neuroblastoma Research and Treatments